Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation
NCT ID: NCT01476293
Last Updated: 2012-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
139 participants
OBSERVATIONAL
2011-08-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Detection of Intravenous Infiltration:A Pilot Study
NCT02553421
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
NCT06758011
Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit
NCT01362088
Ultrasound Detection of Peripheral IV Infiltration
NCT01800552
IV Dislodgement Comparative Effectiveness Study
NCT05602285
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient age under 12
* PIV with continuous fluids
Exclusion Criteria
* patient age over 12
* PIV fluids not continuous
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ivWatch, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darcy Doellman, RN
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Sylvia Rineair, MSHA, BSN
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Neil Johnson, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Michael Spigarelli, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ivWatch-CT-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.